FDA approves The Medicines Co.'s Angiomax

The FDA approved MDCO's Angiomax bivalirudin anticoagulant for use in combination with aspirin to treat patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). ...